Concentra Group Holdings Parent, INC 8-K filings

Concentra Group Holdings Parent, Inc. announced robust second quarter financial results, including significant revenue and net income growth, alongside an increase in full-year 2026 guidance.

Concentra Group Holdings Parent, Inc. announces a consulting agreement with Dr. John R. Anderson following his retirement as Chief Medical Officer.

Concentra Group Holdings Parent, Inc. announced robust first-quarter 2026 financial results, including a 13.7% revenue increase and raised full-year guidance.

Concentra Group Holdings Parent, Inc. successfully concluded its 2026 annual meeting with shareholders electing three directors and ratifying its independent auditor.

Concentra Group Holdings Parent, Inc. announced the upcoming retirement of its Chief Medical Officer, Dr. John Anderson, effective December 31, 2026, after 33 years with the company.

Concentra Group Holdings Parent, Inc. announced robust financial results for Q4 and full-year 2025, exceeding guidance and providing an optimistic outlook for 2026.

Concentra Group Holdings Parent, Inc. announced preliminary unaudited financial results for Q4 and full year 2025, exceeding guidance, and provided a strong 2026 outlook.

Concentra Group Holdings Parent, Inc. announced preliminary, unaudited Q4 and full-year 2025 operational metrics and financial guidance, ahead of its presentation at the J.P. Morgan Healthcare Conference.

Concentra Group Holdings Parent, Inc. granted restricted shares of common stock to its named executive officers, vesting over four years under its 2024 Equity Incentive Plan.

Concentra Group Holdings Parent, Inc. announced robust third-quarter 2025 financial results, including significant revenue and Adjusted EBITDA growth, alongside a raised full-year 2025 guidance and a new $100 million share repurchase program.

Concentra Group Holdings Parent, Inc. announced robust second-quarter results, driven by strong revenue and patient visit growth, and raised its full-year 2025 financial guidance.

Concentra Group Holdings Parent, Inc. announced the appointment of Vipin Gopal and Brigid Bonner to its Board of Directors, effective July 1, 2025, expanding the board to seven members and adding expertise in data, AI, and digital transformation.

Concentra Group Holdings Parent, Inc. has successfully acquired Onsite Innovations, LLC for $55 million, significantly expanding its onsite health clinic operations across the United States.

Concentra reports a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter, along with revised and raised financial guidance for the year.

Concentra Group Holdings Parent, Inc. held its annual meeting of stockholders on May 1, 2025, and approved four proposals, including the election of two Class I directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm.

Concentra Group Holdings Parent, Inc. announces a definitive agreement to acquire Pivot Onsite Innovations from Athletico Physical Therapy for $55 million, significantly expanding its onsite health clinic network.

Concentra reports a successful 2024 marked by revenue growth, strategic initiatives, and the acquisition of Nova Medical Centers, setting a positive outlook for 2025.

Concentra released preliminary 2024 financial results, announced an agreement to acquire Nova Medical Centers, and provided 2025 financial guidance.

Concentra Group Holdings Parent, Inc. discloses the approved 2025 base salaries for its executive officers.

Concentra Group Holdings Parent, Inc. granted restricted stock to several named executive officers, vesting over four years.

Concentra Group Holdings Parent, Inc. has successfully completed its spin-off from Select Medical, distributing shares to Select Medical's stockholders and commencing trading on the NYSE under the ticker CON.

Concentra Group Holdings released an investor presentation outlining its financial performance, growth strategies, and long-term targets, emphasizing its position as a leader in occupational health services.

Concentra Group Holdings announced a 3.3% increase in revenue to $489.6 million for the third quarter of 2024, along with a cash dividend of $0.0625 per share.

Concentra Group Holdings Parent, Inc. has amended its employment agreement with Matthew T. DiCanio, increasing his severance benefits and formalizing his role as President and Chief Financial Officer.

Concentra reported a slight increase in revenue but a decrease in net income for the second quarter of 2024, alongside the completion of its initial public offering.

Concentra Group Holdings Parent, Inc. successfully completed its initial public offering and separated from Select Medical Corporation, establishing itself as an independent entity.